Braco-19 is primarily used in research focused on targeting telomeres, which are protective caps at the ends of chromosomes. It is studied for its potential to inhibit telomerase, an enzyme that plays a critical role in cancer cell proliferation by maintaining telomere length. By disrupting telomerase activity, Braco-19 is explored as a potential therapeutic agent in cancer treatment, particularly in cancers that rely on telomerase for their uncontrolled growth. Additionally, it is utilized in studies to understand the mechanisms of aging and cellular senescence, as telomere maintenance is closely linked to these processes. Its application remains largely experimental, with ongoing investigations to evaluate its efficacy and safety in clinical settings.